Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

1.

How accurate is our clinical prediction of "minimal prostate cancer"?

Leibovici D, Shikanov S, Gofrit ON, Zagaja GP, Shilo Y, Shalhav AL.

Isr Med Assoc J. 2013 Jul;15(7):359-63.

PMID:
23943981
[PubMed - indexed for MEDLINE]
Free Article
2.

The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.

Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H.

J Urol. 2000 Jan;163(1):174-8.

PMID:
10604340
[PubMed - indexed for MEDLINE]
3.

Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.

Gallina A, Maccagnano C, Suardi N, Capitanio U, Abdollah F, Raber M, Salonia A, Scattoni V, Rigatti P, Montorsi F, Briganti A.

BJU Int. 2012 Jul;110(2 Pt 2):E64-8. doi: 10.1111/j.1464-410X.2011.10762.x. Epub 2011 Nov 17.

PMID:
22093108
[PubMed - indexed for MEDLINE]
4.

Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.

Cheng L, Poulos CK, Pan CX, Jones TD, Daggy JK, Eble JN, Koch MO.

J Urol. 2005 Sep;174(3):898-902.

PMID:
16093983
[PubMed - indexed for MEDLINE]
5.

Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores.

Grossklaus DJ, Coffey CS, Shappell SB, Jack GS, Cookson MS.

BJU Int. 2001 Nov;88(7):722-6.

PMID:
11890243
[PubMed - indexed for MEDLINE]
7.

Ability of sextant biopsies to predict radical prostatectomy stage.

Wills ML, Sauvageot J, Partin AW, Gurganus R, Epstein JI.

Urology. 1998 May;51(5):759-64.

PMID:
9610589
[PubMed - indexed for MEDLINE]
8.

Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.

Graefen M, Noldus J, Pichlmeier U, Haese A, Hammerer P, Fernandez S, Conrad S, Henke R, Huland E, Huland H.

Eur Urol. 1999;36(1):21-30.

PMID:
10364651
[PubMed - indexed for MEDLINE]
9.
10.

Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.

Ellis CL, Partin AW, Han M, Epstein JI.

J Urol. 2013 Dec;190(6):2068-73. doi: 10.1016/j.juro.2013.05.056. Epub 2013 May 30.

PMID:
23727307
[PubMed - indexed for MEDLINE]
11.

Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.

Poulos CK, Daggy JK, Cheng L.

Cancer. 2004 Aug 1;101(3):527-32.

PMID:
15274065
[PubMed - indexed for MEDLINE]
Free Article
13.

Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.

Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC Jr; SEARCH Database Study Group.

J Urol. 2003 Jun;169(6):2136-41.

PMID:
12771735
[PubMed - indexed for MEDLINE]
14.

Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.

Oh JJ, Hong SK, Lee JK, Lee BK, Lee S, Kwon OS, Byun SS, Lee SE.

BJU Int. 2012 Dec;110(11 Pt B):E494-9. doi: 10.1111/j.1464-410X.2012.11182.x. Epub 2012 Apr 30.

PMID:
22540236
[PubMed - indexed for MEDLINE]
15.

Factors predicting prostatic biopsy Gleason sum under grading.

Stackhouse DA, Sun L, Schroeck FR, Jayachandran J, Caire AA, Acholo CO, Robertson CN, Albala DM, Polascik TJ, Donatucci CF, Maloney KE, Moul JW.

J Urol. 2009 Jul;182(1):118-22; discussion 123-4. doi: 10.1016/j.juro.2009.02.127. Epub 2009 May 17.

PMID:
19447436
[PubMed - indexed for MEDLINE]
16.

Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study.

Ishizaki F, Hara N, Koike H, Kawaguchi M, Tadokoro A, Takizawa I, Nishiyama T, Takahashi K, Hohenfellner R.

Diagn Pathol. 2012 Jun 14;7:68.

PMID:
22697234
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.

Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL.

BJU Int. 2012 Jul;110(1):36-42. doi: 10.1111/j.1464-410X.2011.10681.x. Epub 2011 Nov 15.

PMID:
22085203
[PubMed - indexed for MEDLINE]
18.

Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.

Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F.

Urology. 2009 May;73(5):1087-91. doi: 10.1016/j.urology.2008.10.048. Epub 2009 Feb 4.

PMID:
19195695
[PubMed - indexed for MEDLINE]
19.

Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms.

Gancarczyk KJ, Wu H, McLeod DG, Kane C, Kusuda L, Lance R, Herring J, Foley J, Baldwin D, Bishoff JT, Soderdahl D, Moul JW.

Urology. 2003 Mar;61(3):589-95.

PMID:
12639653
[PubMed - indexed for MEDLINE]
20.

Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.

Villamón-Fort R, Martínez-Jabaloyas JM, Soriano-Sarriá P, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M.

Urol Int. 2007;78(4):328-33.

PMID:
17495491
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk